| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Point72 Steve Cohen | 338K | $48.19M | NEW |
| Citadel Ken Griffin | 215K | $30.75M | NEW |
| Renaissance Technologies Jim Simons (founder) | 36K | $5.18M | NEW |
| D.E. Shaw David Shaw | 7K | $942.3K | NEW |
| Marshall Wace | 2K | $214.0K | NEW |
ICU Medical Inc. is a medical technology company that develops, manufactures, and sells innovative medical devices for infusion therapy, vascular access, and vital care applications worldwide. Its product portfolio spans three key business segments: Consumables, featuring infusion sets, vascular access products, and specialty chemicals; Infusion Systems, including ambulatory, syringe, and large volume IV pumps with safety software, dedicated and non-dedicated IV sets, needle-free connectors, and informatics services; and Vital Care, offering hemodynamic monitoring, temperature management, airway management, and pain kits. Notable products include needlefree connectors under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock and ChemoClave closed system transfer devices for hazardous drugs; Tego needle-free connectors; Deltec GRIPPER non-coring needles; and various IV therapy solutions like sodium chloride, dextrose, and irrigation products. ICU Medical Inc. serves acute care hospitals, ambulatory clinics, alternate site facilities, and home care settings through direct sales, independent distributors, and partnerships, with a global presence across the U.S., Europe, Asia-Pacific, Middle East, Africa, and other regions. Founded in 1984 and headquartered in San Clemente, California, it plays a critical role in enhancing patient safety, preventing bloodstream infections, and protecting healthcare workers from hazardous exposures in the medical devices sector.
Earnings calendar coming soon. Subscribe to get notified when ICUI reports next.
Get earnings alerts →